Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow INOVIO PHARMACEUTICALS, INC.

Get SEC filing alerts via email and in your feed for INOVIO PHARMACEUTICALS, INC.

INO

INOVIO PHARMACEUTICALS, INC.

About INOVIO PHARMACEUTICALS, INC.

Inovio Pharmaceuticals is a biotech company developing DNA medicines and delivery devices to treat infectious diseases, cancers, and HPV-related conditions. Its platform uses proprietary plasmids and electroporation technology to induce targeted immune responses. Core products include immunotherapies for HPV, glioblastoma, Ebola, and COVID-19, with a focus on in vivo protein production, immune activation, and rapid, scalable manufacturing.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from INOVIO PHARMACEUTICALS, INC.

1
1
INOVIO PHARMACEUTICALS, INC. INOVIO Pharmaceuticals Reports $19.7 Million Net Loss and Seeks Additional Capital

Via official filing (AI summary) | 22 days ago | 0 comments

2
1
INOVIO PHARMACEUTICALS, INC. INOVIO Pharmaceuticals Reports 70% Revenue Decline, Focuses on INO-3107 for RRP

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
INOVIO PHARMACEUTICALS, INC. Inovio Pharmaceuticals Reports $45.5 Million Net Loss and Financial Challenges in Latest Quarter

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
INOVIO PHARMACEUTICALS, INC. Inovio Pharmaceuticals Reports No Revenue and Significant Losses in Latest Financial Filing

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
INOVIO PHARMACEUTICALS, INC. Inovio Pharmaceuticals Reports $19.7 Million Net Loss and First Revenue in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
INOVIO PHARMACEUTICALS, INC. Inovio Pharmaceuticals Reports 74% Revenue Decline and $107.3 Million Net Loss for 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
INOVIO PHARMACEUTICALS, INC. Inovio Pharmaceuticals Reports Significant Financial Challenges, Net Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments